Vitro Biopharma, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Vitro Biopharma, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$1.25M, a 20.7% decline year-over-year.
  • Vitro Biopharma, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$8.91M, a 49.8% decline year-over-year.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$5.38M, a 9.8% increase from 2022.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$5.97M.
  • Vitro Biopharma, Inc. annual Operating Income (Loss) for 2015 was -$158K, a 7.55% increase from 2014.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.38M +$585K +9.8% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 -$5.97M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 -$158K +$12.9K +7.55% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 -$171K -$19.7K -13% Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2013 -$151K +$27.8K +15.5% Nov 1, 2012 Oct 31, 2013 10-K 2015-02-13
2012 -$179K +$23.3K +11.5% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-12
2011 -$202K +$58.8K +22.5% Nov 1, 2010 Oct 31, 2011 10-K/A 2012-02-16
2010 -$261K Nov 1, 2009 Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.